← All organizations

Immune Control

For profit

Highest phase reached

Phase 2

First clinical trial

Jan 1, 2006

Last known activity

Dec 1, 2008

Acquired by Corridor Pharmaceuticals on Jun 17, 2010

Timeline

2000s

  1. Jun 1, 2001

    Immune Control— Founded

2010s

  1. Jun 17, 2010

    Corridor Pharmaceuticals— Acquired By

Drugs by trial phase (1 distinct, 4 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Recent trials (4)

Details

Founded
Conshohocken, PA, US Jun 1, 2001
Last known activity
Dec 1, 2008